Rainer Fischer

Rainer Fischer In the ancient imperial city of Aachen, a global strategy for antibodies and vaccines from plants and microbes is being planned. By Hildegard Kaulen In the early Middle Ages, the German city of Aachen was the northern capital of Charlemagne's empire. Today, the city is home to western Europe's largest technical university (Technical University in Aachen), the only one in North Rhine-Westphalia (NRW) given elite status in Germ

Written byHildegard Kaulen
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

By Hildegard Kaulen

In the early Middle Ages, the German city of Aachen was the northern capital of Charlemagne's empire. Today, the city is home to western Europe's largest technical university (Technical University in Aachen), the only one in North Rhine-Westphalia (NRW) given elite status in Germany's recent Initiative for Excellence competition. In the last 25 years Aachen has been an incubator for over 1,000 start-up companies.

One of the university's leading figures is Rainer Fischer. Hs immense energy and resourcefulness have helped to build up a global network for the implementation of biotechnological inventions made in NRW. Fischer holds a chair of molecular biotechnology at the Technical University and is senior executive director of the Fraunhofer Institute for Molecular Biology and Applied Ecology. The institute is a special unit of the Fraunhofer Society dedicated to contract research, which earns two-thirds of its budget from research work done on commission. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies